Literature DB >> 8943966

Impact of Helicobacter pylori colonization on immunoreactive epidermal growth factor and transforming growth factor-alpha in gastric juice. Its potential pathogenetic implications.

M Marcinkiewicz1, B Van Der Linden, D A Peura, G Goldin, S Parolisi, J Sarosiek.   

Abstract

Epidermal growth factor (EGF), pivotal in mucosal protection, is partly degraded proteolytically at low pH in the gastric milieu; gastric acid secretion, on the other hand, remains influenced by H. pylori colonization. The aim of this study, therefore, was to evaluate the impact of low pH and H. pylori colonization status on immunoreactive EGF and the other member of EGF-family, immunoreactive transforming growth factor-alpha (TGF-alpha). Eighteen patients with nonulcer dyspepsia (NUD) colonized by H. pylori and 55 NUD patients without H. pylori colonization were investigated. Gastric juice samples were aspirated at the beginning of the endoscopy procedure and immediately placed on ice, and their pH was recorded. The measurement of immunoreactive EGF and TGF-alpha was performed using commercially available radioimmunoassays (RIAs) after adjustment of pH to neutral using an assay buffer. Statistical analysis was performed using sigma-Stat for Windows. The concentration of immunoreactive EGF in patients with NUD colonized by H. pylori was 80% lower (P < 0.02) than in those without H. pylori and in both groups immunoreactive EGF was significantly lower when the pH of gastric juice was below 4.0. The concentration of immunoreactive EGF in H. pylori(+) and H. pylori(-) patients was similar when the pH of aspirated gastric juice was above 4.0. However, with gastric juice pH < 4.0, the EGF concentration was 64% lower in H. pylori(+) patients than H. pylori(-) patients (P < 0.05). In general, the concentration of immunoreactive TGF-alpha in gastric juice was unaffected by H. pylori colonization or pH of gastric juice. It is concluded that: (1) significantly lower immunoreactive EGF concentrations in patients with pH below 4.0 indicate that immunoreactive EGF but not immunoreactive TGF-alpha is affected by an acidic gastric milieu; (2) the further reduction of gastric juice immunoreactive EGF at pH below 4.0 in patients colonized by H. pylori suggests that this microorganism may elaborate factors that accelerate its proteolytic degradation or inhibit its rate of synthesis and/or secretion; and (3) this diminished content of immunoreactive EGF at low pH, especially in patients colonized by H. pylori, may facilitate the development and/or progression of mucosal damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943966     DOI: 10.1007/bf02071394

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Application of trinitrophenylation for the measurement of alpha-amino residues resulting from peptic digestion.

Authors:  M T Yuko; K Hotta
Journal:  Biochim Biophys Acta       Date:  1977-04-12

Review 2.  Gastric mucus and the mucosal barrier.

Authors:  B L Slomiany; J Sarosiek; A Slomiany
Journal:  Dig Dis       Date:  1987       Impact factor: 2.404

3.  Prostaglandin effect on the physical properties of gastric mucus glycoprotein and its susceptibility to pepsin.

Authors:  J Sarosiek; V L Murty; C Nadziejko; A Slomiany; B L Slomiany
Journal:  Prostaglandins       Date:  1986-11

4.  Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.

Authors:  J Sarosiek; J Bilski; V L Murty; A Slomiany; B L Slomiany
Journal:  Am J Gastroenterol       Date:  1989-05       Impact factor: 10.864

5.  Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice.

Authors:  R J Playford; T Marchbank; D P Calnan; J Calam; P Royston; J J Batten; H F Hansen
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

6.  Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.

Authors:  R M Rourk; Z Namiot; M C Edmunds; J Sarosiek; Z Yu; R W McCallum
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

7.  The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat.

Authors:  J Sarosiek; T Feng; R W McCallum
Journal:  Am J Med Sci       Date:  1991-12       Impact factor: 2.378

Review 8.  Gastroduodenal mucosal protection.

Authors:  A Allen; G Flemström; A Garner; E Kivilaakso
Journal:  Physiol Rev       Date:  1993-10       Impact factor: 37.312

9.  Human esophageal secretion: mucosal response to luminal acid and pepsin.

Authors:  Z Namiot; J Sarosiek; R M Rourk; D P Hetzel; R W McCallum
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

10.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

View more
  1 in total

1.  Helicobacter pylori infection and gastrointestinal hormones:a review.

Authors:  Xiang-Qian Huang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.